Quest plans to use the net proceeds for general corporate purposes, which may include repaying debt such as $500 million in senior notes maturing on June 1.

The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.

Comprising more than 20 firms and organizations across the infectious disease space, the compact will address issues like test access and data fragmentation.

Earlier this month, the CDC said it was temporarily pausing testing for a range of diseases including rabies, poxviruses, the Epstein-Barr virus.

Last week, readers were most interested in an update from Roche at ESCMID about its tuberculosis testing business.

In a session on the impact of IVDR on molecular testing, presenters noted a lack of clarity and flexibility while endorsing new amendments.

The firm presented data at AACR this week showing the improved performance of its molecular pancreatic cancer early detection assay.

The firm's overall sales declined 5 percent due to the significant appreciation of the Swiss franc compared to most other currencies.

The new tests could help detect malaria in cases where plasmodium parasites carry gene deletions impacting traditional rapid diagnostics.

The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.

NEW YORK – Germany's Wilhelm Sander Foundation said on Friday that it is granting approximately €1 million ($1.2 million) to a research team at Ludwig Maximilian University of Munich and the Max ...